Rating Change
RBC Capital reiterated its Sector Perform rating on PTC Therapeutics, Inc. (NASDAQ:PTCT) on October 08, 2026.
reiterateNASDAQ:PTCT
RBC Capital Reiterates Sector Perform Rating on PTC Therapeutics, Inc. (PTCT)
RBC Capital reiterated its Sector Perform rating on PTC Therapeutics, Inc. (NASDAQ:PTCT) on October 08, 2026.
At publication ·
What changed
PTC Therapeutics, Inc. (NASDAQ:PTCT) · reiterate
- Firm
- RBC Capital
- Rating
- Sector Perform to Sector Perform
- Price at event
- $62.30
- Market capitalization
- $6.1B
At a glance
Key takeaways
- RBC Capital maintained its Sector Perform rating on PTC Therapeutics on October 8, 2026, suggesting performance aligned with healthcare sector expectations.
Market Context
PTC Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $62.30 with a market capitalization of $6.1B. The stock has declined 4.3% over the past 52 weeks.
Analyst coverage from RBC Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for PTC Therapeutics, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for PTC Therapeutics, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 08, 2026 | RBC Capital | Sector Perform | N/A |
| Sep 22, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Aug 14, 2026 | Barclays | Overweight | N/A |
| Aug 13, 2026 | Wells Fargo | Overweight | N/A |
| Jul 31, 2026 | Morgan Stanley | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View PTCT Stock Page
Frequently Asked Questions
What does the Sector Perform rating mean for PTCT?
A rating of Sector Perform from RBC Capital reflects the analyst's outlook on PTC Therapeutics, Inc. (NASDAQ:PTCT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PTCT forecast page.